LinkMed: Year-end Report 2006.STOCKHOLM, Sweden -- Important events in the fourth quarter * LinkMed (STO:LMED) was listed on the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries. following a new share issue of SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 195.6 million * AbSorber entered into an agreement with BD for the transplantation cross-match test XM-ONE, which was launched in December * New portfolio company Ortoviva * LinkMed and the Norrland Fund invested SEK 4.5 million in BioResonator Important events after the period end * Biovator's allergen allergen /al·ler·gen/ (al´er-jen) an antigenic substance capable of producing immediate hypersensitivity (allergy).allergen´ic pollen allergen test receives SEK 3.5 million from EUREKA Eureka (y  rē`kə), port city (1990 pop. 27,025), seat of Humboldt co., NW Calif., on Humboldt Bay; inc. 1856. Financial information for the period * Profit/loss from investment operations amounted to SEK -2.5 million (-0.4) in the period, with SEK 0.0 million (-0.4) in the fourth quarter * Other income amounted to SEK 4.0 million (3.6), with SEK 1.3 million (0.6) in the fourth quarter * Profit/loss after tax amounted to SEK -14.5 million (-3.5), with SEK -4.0 million ( 1.5) in the fourth quarter * Earnings per share were SEK -2.58 (-0.86) * Shareholder equity totaled SEK 296.2 million (64.1). Equity per share totaled SEK 33.96 (14.27) * Equity/assets ratio was 97 (94) percent * Cash and bank balances increased to SEK 202.7 million (2.9) Important events during the fourth quarter Associated companies associated company associate n → Partnerfirma f associated company n → società collegata AbSorber enters into an agreement with BD for XM-ONE In November, AbSorber entered into an agreement with the U.S. company BD (BectonDickinson and Company) for the distribution of the transplantation test XM-ONE. Under the agreement, BD receives exclusive rights to distribute XM-ONE in all markets, apart from the Nordic region. BD launched the test in Europe in December. AnaMar Medical begins out-licensing In November, AnaMar Medical began the out-licensing process for three drug candidates: AMAP AMAP Arctic Monitoring and Assessment Programme AMAP As Much As Possible AMAP As Many As Possible AMAP American Medical Accreditation Program AMAP Army Medical Action Plan AMAP Automotive and Manufacturing Advanced Practice 102 for rheumatoid arthritis rheumatoid arthritis Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course. , CS-E for wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by and SCI (Scalable Coherent Interface) An IEEE standard for a high-speed bus that uses wire or fiber-optic cable. It can transfer data up to 1GBytes/sec. (hardware) SCI - 1. Scalable Coherent Interface. 2. UART. for spinal injuries. Ortoviva AB a new associated company In October, LinkMed made the decision to invest up to SEK 12 million in the recently formed company Ortoviva AB, a company that develops surgical tools for spinal surgery. LinkMed's ownership stake in Ortoviva is 49 percent. In December, Sven Gustafsson was appointed chairman of the company. Sven has many years of experience in medical electronics from Siemens-Elema and Fresenius. He also founded and manages the medtech equipment company Dicamed, which is active in the field of heart surgery and anesthesia. LinkMed and the Norrland Fund invest in BioResonator In December, LinkMed contributed SEK 2.0 million to BioResonator through a new share issue and the Norrland Fund contributed SEK 2.5 million in the form of a convertible. Financial operations and corporate governance Corporate Governance The relationship between all the stakeholders in a company. This includes the shareholders, directors, and management of a company, as defined by the corporate charter, bylaws, formal policy, and rule of law. LinkMed is listed on the Stockholm Stock Exchange The LinkMed share was listed on the Stockholm Stock Exchange on December 12, 2006. In conjunction with the listing, a new share issue was executed at a price of SEK 70 per share, which generated SEK 195.6 million for the company after listing costs. At the period end, LinkMed had approximately 2 300 shareholders. The number of shares totaled 8 721 985 following the new share issue. LinkMed strengthens the organization In December, Yvonne Axelsson was appointed financial manager. Yvonne previously ran her own consultancy firm and has been involved with LinkMed in her role as consultant since the beginning of 2006. Important events after the report period Biovator's allergen test receives SEK 3.5 million from EUREKA In January, Biovator formed a project for the final-phase development of an in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. test that predicts if chemical substances may cause allergic reactions allergic reaction n. A local or generalized reaction of an organism to internal or external contact with a specific allergen to which the organism has been previously sensitized. . The project received a grant from EUREKA for half of the development costs, which are estimated at SEK 7.0 million. Important events during the year Associated companies LinkMed sold all shares in Pegasus lab In February, LinkMed sold all shares in Pegasus lab AB. The sale of Pegasus lab has had no effect on LinkMed's 2006 income. LinkMed invests in AnaMar Medical and IMED IMED International Medical Education Directory In April, the LinkMed board resolved to invest SEK 8.0 million in AnaMar Medical and SEK 3.0 million in IMED. LinkMed invests in AbSorber In June, LinkMed invested SEK 3.0 million in Absorber. New CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. at SACS Medical In June, LinkMed's senior venture manager Stan Mikulowski was appointed as the new CEO of SACS Medical. LinkMed invests in Recopharma In September, LinkMed provided SEK 9.5 million in financing for the associated company Recopharma through debt instrument conversion as well as committing to invest SEK 6.0 million in a convertible. Recopharma is using the investment to study the effect of vaccine adjuvants in animal models. Three new staff members have also been employed to strengthen the organization. Financial operations and corporate governance LinkMed receives SEK 4.6 million through an options program In April, stock option holders in LinkMed executed a matured stock option program of 165 000 at a strike price of SEK 28 per share. The program was fully executed, resulting in a capital injection of SEK 4.6 million to LinkMed. Conversion of convertible bonds increases the number of shares by 3 percent In March, all bearers BEARERS, Eng. crim. law. Such as bear down or oppress others; maintainers. In Ruffhead's Statutes it is employed to translate the French word emparnours, which signifies, according to Kelham, undertakers of suits. 4 Ed. III. c. 11. This word is no longer used in this sense. of convertible bonds converted the bonds to shares, this resulted in an increase in the number of shares by 137 275. LinkMed secures SEK 43.1 million through new share issue with preferential rights A new share issue with preferential rights was executed in April, with a mandate from the Annual General Meeting. A holding of five shares entitled the holder the right to subscribe to Verb 1. subscribe to - receive or obtain regularly; "We take the Times every day" subscribe, take buy, purchase - obtain by purchase; acquire by means of a financial transaction; "The family purchased a new car"; "The conglomerate acquired a new company"; one new share at an issue price of SEK 50. The new share issue was fully subscribed Fully Subscribed A situation in which an underwriting firm has successfully sold to investors all of its available issues of a public offering of securities. When the issue is fully subscribed, the underwriter's risk of being undersubscribed (being unable to sell its allotment of , resulting in an issue of 926 164 new shares and a net capital injection of approximately SEK 43.1 million to the company, after deduction of issuing costs. Monica Caneman new chairperson Monica Caneman, Sven-Olof Johansson and Agneta Edberg were appointed as new board members at LinkMed's Annual General Meeting on April 26. Monica Caneman was appointed as chairperson. Gunnar Mattsson, Anders Erlandsson and Jan Eriksson Jan Eriksson (born August 24, 1967 in Sundsvall) is a former footballer from Sweden. He played 35 matches and scored 4 goals for the national team. 2 of those goals came at the Euro 1992. He was selected for the 1990 FIFA World Cup squad, but didn't play. were re-elected. Ingemar Lagerlof new CEO Ingemar Lagerlof, LinkMed's founder, who previously acted as senior venture manager at the company, took over the CEO position from Olle Johansson in June. Other information LinkMed forms a scientific advisory board In April, LinkMed formed a scientific advisory board whose task is to evaluate the opportunities and risks of associated company projects and products, as well as new investment proposals. The advisory board is chaired by associated professor Bengt-Goran Hansson, previously head of the Medicinkliniken in Halmstad, among other positions. Lars Martin new senior venture manager In June, Lars Martin was employed as senior venture manager. Lars joined LinkMed from MSD (MicroSoft Diagnostics) A utility that accompanied Windows 3.1 and DOS 6 that reported on the internal configuration of the PC. A variety of information on disks, video, drivers, IRQs and port addresses was provided. and has previously held various management positions in the pharmaceutical industry. Write-down of holding in SACS Medical, preparation of sale LinkMed made a downward adjustment of the value of its holding in SACS Medical by SEK 2.5 million in September. Together with other shareholders, LinkMed is preparing the sale of the company. About LinkMed LinkMed, in collaboration with innovators and other financiers, develops new life science companies. By contributing entrepreneurship and capital, LinkMed has created a portfolio of ten companies, six in drug development and biotechnology and four in medical technology. LinkMed's roll changes as the portfolio companies develop. With time, the work emphasis moves from operational to strategic as the entrepreneurship role evolves into active board work. Principle owners are FastPartner, Koncentra Holding, Mannerson Fastigheter and the founder, Ingemar Lagerlof. See linkmed.se for more information. This year-end report presents unaudited annual earnings that have not been reviewed by company auditors. This information was brought to you by Waymaker http://www.waymaker.net |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion